If your AI, SaaS, Health Tech, RWD/RWE, Telecom or Cybersecurity business is struggling to consistently achieve growth goals...

We should talk.

Executive Bio

Download My Resume

Greg Tennant, Gregory Tennant, gregorytennant.com

Meet Gregory Tennant

Book Now

Executive Bio

Gregory Tennant
Chief Strategy & Commercialization Officer
AI, SaaS, Health Tech, RWD/RWE and Cybersecurity

SUMMARY

Gregory Tennant is a transformational B2B and DTC commercialization executive with over two decades of experience generating economic life for innovative technologies by building scalable revenue engines across biotechnology, SaaS, healthcare analytics, telecommunications, and cybersecurity. His expertise lies in defining the market, harnessing the voice of the customer, streamlining product development, and executing go-to-market strategies to achieve product-market fit, scalable revenue growth, and establish dominant market positions for Fortune 50 enterprises and emerging Series A ventures alike. Gregory embodies the diverse capabilities that comprise effective commercialization: 1)Market Analysis - Identify and validate the opportunity and aligning the product with the real market need, 2)Agile Product Development - Define and develop the solution - streamlining the process of delivering value, 3)Go-To-Market Strategy, Planning and Execution – Driving market presence – honing account access and penetration. 4)Revenue Marketing - Target, Reach & Persuade market adoption - compelling market adoption. 5)Brand Marketing – Positioning the company for market dominance.

FORMATION

Gregory’s acumen in market entry and expansion was cultivated early in his career as a Senior Consultant at Markowitz & McNaughton (now The NxtMove), where he advised multinational corporations such as GE, 3M, Ford Motor Company, BASF, Siemens Healthcare, and Mitsubishi. Through rigorous primary research, competitive analysis, and M&A due diligence, Gregory crafted strategic frameworks that empowered these organizations to penetrate new markets, disrupt established industries, and scale globally. Building on this foundation, Gregory led strategy for AT&T Federal Systems, where he managed cross-functional teams to commercialize groundbreaking innovations from AT&T Bell Labs. His portfolio included the first ATM-based video conferencing system, advanced parallel processing platforms for speech recognition, and active noise cancellation technology. These early achievements reflect Gregory’s ability to align innovations with real-world use cases, unlocking commercial and governmental market opportunities.

RECENT HEALTH TECH EXPERIENCE

Currently serving as Chief Marketing and Product Officer at Network.bio, Gregory is revolutionizing the real-world data (RWD) and real-world evidence (RWE) market. Under his commercialization leadership, Network.bio has secured partnerships with six major academic medical centers and developed advanced platforms for federated biomedical analytics, dynamic data integration, and fit-for-purpose disease-specific datasets, accelerating precision medicine development in oncology and chronic hereditary diseases. Gregory’s career includes experience in healthcare technology, RWD, and RWE commercialization, where he has delivered impactful solutions to a diverse range of stakeholders, including pharma companies, healthcare providers, payors, PBMs, pharmacies, and EMR vendors. His ability to navigate complex ecosystems has resulted in the development of over twenty innovative products, including AI-based primary adherence solutions and network-based distributed clinical trial enablement platforms, while enabling significant revenue growth and client expansion. Previously, as Head of Product and Go-To-Market at M2Gen, Gregory defined the strategy that drove a $100 million investment and tripled the company’s sales by redefining its oncology AI and RWD offerings. His leadership roles at Inspirata, DrFirst, and MedHOK underscore his expertise in scaling revenues, implementing agile methodologies, and delivering measurable business impact.

INTERNATIONAL EXPERIENCE

His international experience spans North America, Latin America, Europe, Asia, and the Middle East, where he has successfully positioned products for diverse markets, including navigating complex nationalized healthcare systems. From digital pathology solutions to clinical trial enablement platforms, Gregory’s work reflects his ability to tailor strategies that resonate across cultural and regulatory landscapes.

PHILANTHROPY

Beyond his professional achievements, Gregory actively supports organizations like the Make-A-Wish Foundation, Marfan Foundation, and the Knights of Columbus. Through his volunteer work and advocacy, he has raised significant funds and championed meaningful causes on Capitol Hill and beyond.

EDUCATION & HONORS

Gregory holds advanced certifications in Strategic Marketing from Duke University’s Fuquay School of Business and International Trade & Finance from Cornell Johnson School of Management, complementing his B.S. in Economics and Business Management from Cornell University, and earned Academic All-American honors.

SUMMARY

Gregory Tennant’s career reflects a singular ability to identify unrecognized opportunities, build markets, and deliver exceptional value. His unique perspective, shaped by experience across industries, markets, and cultures, consistently drives transformative growth.

Resume

DOWNLOAD

Raleigh, NC gtennant4@gmail.com 727.235.4450 /in/gtennant https://GregoryTennant.com

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

SUMMARY

Driving scalable revenue growth via deep market analysis to create excellent product-market fit, differentiated positioning and messaging, and strategic market expansion in AI, SAAS, software, cybersecurity, and data analytics for Series A-D health tech companies.

---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

EXPERIENCE

CCO - Chief Marketing & Product Officer

Network.bio, Inc. (Stealth Phase) May 2023 to Present, New York, NY

Defined product and market strategy for this stealth mode AI start-up focused on generating clinical, genomic, and imaging real-world data (RWD) and real-world evidence (RWE) to enable pharma to build targeted precision therapies in chronic disease areas using AI.
Successfully built a pipeline with 15 large academic medical centers with six (6) contracted in year 1 enabling over 1,200,000 biospecimens in gastrointestinal, immunology and oncology for advanced data curation for pharma clients.
Developed cloud-based biomedical analytics platform and data integration platform to enable scalable growth and expanded revenue offerings to pharma and biotech clients.

Head of Product & Go-To-Market Planning

M2Gen, Inc. (Now Zephyr AI) Jun 2020 to May 2023, Tampa, FL

Repositioned this oncology RWD and AI analytics provider to drive revenue growth and client expansion by realigning product-market fit and new product expansion resulting in 13 new pharma clients and over $80 million in new annualized revenues.
Expanded data and AI analytics offerings via coordinated development with 20 NCI designated cancer centers known as the ORIEN Network to include clinical data, genomic sequencing, liquid biopsy, and pathology imaging to expand revenue per client by 35%.
Successfully developed a cloud-based AI-enabled bioinformatics platform enabling federated data analysis and permission-based data access to enable pharma and ORIEN collaborations for clinical trial enablement.

CMO - Chief Strategy & Marketing Officer

Inspirata, Inc. (Now FujiFilm) Dec 2018 to Jun 2020, Tampa, FL

Enabled 23 global sales executives to operate in a single CRM to scale lead management and deal progression and to expand their sales funnel by 300% and close over $80 million in new annualized revenue.
Repositioned company after completing four (4) new acquisitions from a digital pathology company to an oncology analytics insight provider with an enterprise-level value proposition that leveraged our discrete product incumbency at healthcare providers.
Developed marketing tech stack enabling growth marketing and targeted demand generation programs for AI-based genomics interpretation and AI-based clinical trial matching gaining over 450 new global cancer centers and 10 life sciences clients.

CMO - VP Corporate & Product Marketing

DrFirst, Inc. April 2017 to Dec 2018, Rockville, MD

Successfully provided commercialization support for 17 separate sales channels achieving record company revenue growth of 120% via innovative digital marketing programs, integrated marketing strategies, and coordinated lead and opportunity management.
Managed Corporate Marketing Group with 22 experts performing Product and Segment Marketing, Digital Marketing, Solutions Development, Strategic Planning, PR, Lead Generation, Advertising, Competitive Analysis, Communications, Events & Promotions, Demo & RFP.
Supported development of 20 new products targeting healthcare Providers, Payers, PBMs, Pharmacies, Post-Acute, and EMR vendors, including an AI-based primary adherence solution that reached 4 million patients in year one and seven new Pharma clients.

CMO - Senior Vice President Product & Marketing

MedHOK, Inc. (dba MHK) Jan 2015 to Apr 2017, Tampa, FL

Enabled rapid revenue growth and new Payer logo expansion via SaaS-based Core Administrative Process applications and professional services implementations with 200% annualized growth rate and ranked Top 25 INC 500 and Deloitte Fast 250.
Managed Marketing, Product Development and Management, Technology, Business Development, Sales Operations, Sales Engineering, Strategic Planning, Press Relations, Lead Generation, Brand Development, Advertising, Competitive Analysis, Communications, Events & Promotions, Release Management, Demo & RFP with a team of 33 professionals.
Built marketing stack for growth marketing programs supporting a domestic sales team of 12 executives. Implemented Agile-based SDLC process to improve quality and delivery improving bug fix metrics by over 40%. Flipped RFP win rate from 25% to 95% and increased sales pipeline activity over 325%.

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

ADDITIONAL PROFESSIONAL EXPERIENCE

Cybera, Inc. – CMO – SVP Marketing, Product & Strategy - Cybersecurity
Luminosity Communications, Inc. – CEO – Enterprise SaaS
Progress Telecom, LLC – CMO – SVP Marketing, Product & Strategy – Fiberoptics
Epik Communications, Inc. – CEO – Fiberoptics
Argus Systems Group, Inc. – SVP Secure Appliance Division – Cybersecurity
Convergent Communications, Inc. – CMO – SVP Managed Services Division – Data Communications & Enterprise SaaS
Intermedia Communications, Inc. – Director Data Products – Data Communications
AT&T Paradyne, Inc. – Sr Manager Data Product Strategy – Data Communications Equipment
AT&T Federal Systems, Inc. – Sr Manager Strategy – Defense Technology
Markowitz & McNaughton, Inc. (Now NxtMove) – Senior Consultant – Management Consulting
Fails Management Institute, Inc. – Analyst – Management Consulting

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

PROJECTS

Volunteer - Make-A-Wish

Make-A-Wish * https://wish.org/sfla * February 2017 -Present

Raised over $8,000 in donations for the Make-A-Wish of South Florida organization.
Participated in four (4) marketing productions demonstrating efficacy of wishes.
Participated in the Wish granting process and events for nine (9) candidate children.

Volunteer – Marfan Foundation

Marfan Foundation * https://marfan.org * February 2012-Present

Advocated four (4) separate times on Capitol Hill for legislative support of NIH funding for rare disease research.
Hosted 12 awareness booths at events to educate the public on symptoms and signs of Marfan Syndrome.
Support fund raising events to raise funding for the Marfan Foundation totaling over $15,000.

Volunteer – Knights of Columbus

Knights of Columbus – Third Degree * https://www.knightsofcolumbus12281.org/contact * January 2013-Present

Supported charitable outreach, fund raising, and support for over 100 church and parishioner projects.
Participated in more than 50 business and planning meetings for organizational budgeting, planning and support.
Helped raise over $4,000 for organizational funding to be used on donations for needy parishioners.

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

SKILLS

Executive Leadership; Growth Marketing; Demand Generation; Product Development; Product Management; Product Commercialization; Agile Framework; DevOps; SAAS; Cybersecurity; Software; Data; Analytics; AI; ML; NLP; Clinical RWD; RWE; Molecular Data; Imaging Data; Product Marketing; Corporate Marketing; Branding & Positioning; Market Messaging; Digital Marketing; SEO; Event Management; Social Media; Influencer Marketing; PR; Go-To-Market; Sales; Business Development; Partnerships; Strategic Planning; Product Roadmap; Budgeting; Business Financial Planning; Voice of Customer; Pharma Drug Development; Payer Core Administrative Processes; PBM Formulary; and Provider EMR and Diagnostic Systems.

------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

EDUCATION & HONORS

Duke University Fuquay School of Business – Durham, NC

Strategic Marketing Management Certification - Executive MBA Program Course

Cornell Johnson School of Management – Ithaca, NY

International Trade & Finance MBA Courses

Cornell University – Ithaca, NY

B.S. Economics & Business Management

Louisburg College - Louisburg, NC

A.A. Liberal Arts

HONORS

Being the Father of Two Incredicle Kids
Seven Product of the Year Awards
Gartner Magic Quandrant Market Leader
Gartner Cool Vendor
Security Committee Leader for ASP
Academic All-American
Division I Basketball
Outstanding College Students of America

Advisory Experience

In addition to his executive leadership roles, Gregory Tennant has an extensive background in consulting with globally recognized companies, providing expertise in market entry strategies, strategic acquisition programs, primary market assessments, competitive analysis, market attractiveness evaluations, roadmap development, prioritization, and voice-of-the-customer programs. His advisory work has supported industry giants such as:

BASF
GE
Honeywell
Mitsubishi
3M
Rand McNally
Grumman Aerospace
Ford Motor Company
St. Jude Medical
Bowater Industries
Motorola
Siemens Healthcare
Sumitomo Industries
BCE Telecom
Boyle-Midway
And many others

Gregory’s strategic insights have driven successful product launches, market expansions, and transformative mergers. For example, he executed acquisition market due diligence for the Boyle-Midway and Reckitt Coleman merger, which consolidated the consumer goods market into two dominant players: the NewCo and SC Johnson. His ability to synthesize market intelligence, competitive dynamics, and strategic opportunities has proven invaluable across industries.

Additionally, Gregory has served as a trusted advisor to multiple start-up companies in healthcare technology, biotechnology, and cybersecurity. Leveraging his deep understanding of market dynamics and commercialization, he has guided early-stage enterprises toward scalable growth and sustainable competitive positioning. Regardless of the company’s size, Gregory emphasizes a market-first approach, followed by product alignment, to develop scalable growth strategies that deliver measurable results.

Graphic depicting areas of strategic advising

Invert Your Security Priorities...Now

Security Magazine 8/1/2014 By Gregory Tennant With more than 600 high-profile network breaches in 2013, it is clear that traditional...

gtennant4

How Technology Drives Profit

Convenience Store News 3/9/15 By Gregory Tennant Giant names in the convenience store sector such as Shell, BP, Chevron and ExxonMobil...

gtennant4

Unlocking Executive Success: Gregory Tennant's Journey in Biotech

In the fast-paced world of biotech, success often hinges on the leadership and vision of top executives. One individual who has made...

gtennant4

Maximizing Leadership Impact: Gregory Tennant's Success in Cybersecurity

In the fast-evolving world of cybersecurity, strong leadership is key to navigating the complex challenges and threats that organizations...

PORTFOLIO EXAMPLES

The CEO of Inspirata tasked Greg as Chief Strategy, Marketing and Product Officer to rebrand the company after a series of acquisitions that significantly changed the scope of the portfolio and core value proposition. Greg worked cross-functionally with business line leaders to build consensus while ensuring corporate branding efforts did not impact revenue marketing programs. Inspirata acquired unique AI capabilities when it acquired Artificial Intelligence in Medicine (AIM), Caradigm (from GE) and Omnyx (from GE) that facilitated information delivery products designed to solve insight gaps in clinical and research use cases. Greg successfully launched the repositioning of Inspirata and defined a targeted brand positioning video to re-introduce the company as uniquely positioned to solve data delivery and insight creation deficiencies within global cancer centers.

Meanwhile Greg developed targeted campaigns designed to drive specific product area growth such as the Digital Pathology piece produced by Greg’s team and utilized in programs promoted through trade magazines such as Digital Pathology Magazine, along with sponsored webinars. The product awareness and demand generation programs were designed to establish Inspirata as the market leader enabling Ohio State university to build a pathology image library of over one million images, where no competitor in the market could demonstrate scalability.

The Pathologist article celebrating the one millionth H&E slide being imaged at Ohio State James cancer Center

REFERENCES

HOW GREG HAS POSITIVELY IMPACTED HIS EMPLOYERS

Network.Bio, Inc. – Reshaping the RWD-to-RWE Development Pipeline

Asad Ali Ahamad – Network.Bio Co-CEO

“From our first discussion with Greg we knew he knew this market better than anyone we had ever talked to prior. Greg’s constructive challenges, directness, unique perspectives, fundamental business acumen, and multi-threat commercialization capabilities were instrumental to Network.Bio constructing and building a directed plan that will change our industry and drive cures for many overlooked diseases.”

Gregory Tennant joined Network.Bio in May 2023, bringing with him insights gained from reshaping M2Gen’s go-to-market model and addressing structural challenges that had nearly derailed the organization. At Network.Bio, Gregory collaborated closely with the company’s founders to redefine its strategy, shifting the economics of non-reimbursed genetic testing for diseases beyond oncology and addressing a critical gap in the market. Gregory implemented a demand-driven biospecimen characterization model, ensuring that Network.Bio focused on generating the specific precision medicine datasets that the market required. This approach enabled the company to target partnerships with precision, while delaying significant genetic sequencing costs until contracts were secured and provide pharma clients with fit-for-purpose data sets with disease-specific genetic characterization of statistical significance. These datasets also facilitated opportunities for re-engaging patients in clinical trials or observational studies. This achievement provided access to over 1.2 million biospecimen across gastrointestinal, immunology, and oncology domains, supporting advanced data curation for pharmaceutical clients. Additionally, Gregory spearheaded the development of a cloud-based biomedical analytics and data integration platform, enabling scalable growth and expanding revenue opportunities for pharma, biotech industries and Academic Medical Centers.

Intermedia Communications – Driving $350M Annualized Revenue in Three Years

David C. Ruberg – Intermedia Communications CEO

“Greg’s strategy proved to be brilliant and disrupted the entire data communications market. It was simply the most strategic product we had.”

Greg Tennant was hired by the CEO of Intermedia Communications (ICI) to commercialize the company’s Frame Relay data networking services, an ambitious endeavor in a market dominated by industry giants like AT&T, MCI, Sprint, and WorldCom. Tasked with rebuilding the network from the ground up within two months, Greg identified a critical weakness in competitors’ strategies: they relied on voice network architectures that undermined Frame Relay's self-healing capabilities and imposed costly backhaul requirements on customers. He capitalized on this gap, pioneering a mesh network approach that targeted underserved Tier 2 and Tier 3 cities, initially in Florida and later across the United States. Recognizing the challenge of establishing brand recognition in a crowded market, Greg forged a groundbreaking interconnection agreement with BellSouth. This not only provided cost-effective access circuits and inter-LATA connectivity but also unlocked the power of BellSouth’s entrenched sales teams. He attended BellSouth’s North Carolina annual sales meeting and, over a sponsored lunch, reframed their recent losses to competitors, positioning ICI as the solution to “connect the dots” for clients. This innovative partnership model was expanded to Bell Atlantic, Nynex, Ameritech, and US West, creating an army of motivated collaborators who invited Intermedia into client sales meetings as trusted partners. Under Greg’s leadership, Intermedia became a juggernaut, leveraging these partnerships to win contracts with state governments across the East Coast and secure its position as the third-largest Frame Relay provider in the U.S., achieving $350 million in annualized revenues in just over three years. Gartner named Intermedia a market leader in Frame Relay for two consecutive years, validating the effectiveness of Greg’s strategy. His portfolio of data products—including Frame Relay, Internet Access, Hosting, ATM, and Management Services—were not only profitable but also pivotal to the company’s growth trajectory.

Cybera, Inc. – Doubling Sales in Two Years and Driving Strategic Investment

Cliff Duffey – Cybera, Inc. CEO

“Greg is one of the brightest Marketing leaders that I have known in the network service industry. He has a very entrepreneurial approach to attacking business opportunities and could bring a lot of value to other high-growth companies.”

Greg Tennant was brought on by the CEO of Cybera, Inc. to reposition the company’s offerings in the market and attract new investors to buy out existing stakeholders. At the time, Cybera was a Security-as-a-Service provider specializing in cloud-based cybersecurity solutions for large, distributed enterprises. The challenge came amidst a wave of high-profile breaches at companies like Target and Office Depot, where Point-of-Sale (POS) networks were compromised, often via lateral attacks originating from other high-risk network segments or remote access points. Gregory identified a critical flaw in traditional network architecture: dynamically routed networks allowed lateral propagation of breaches, exposing sensitive systems like POS to significant vulnerabilities. He redefined Cybera’s product offering by introducing an application-specific private IP wide area network (WAN) that isolated POS systems from dynamic traffic, effectively eliminating breach propagation risks. This groundbreaking approach enabled Cybera to launch the first Software-Defined Network (SDN) in the market, delivering a transformative solution that addressed pressing PCI compliance concerns. Gregory’s innovative product strategy led to major wins, including securing the entire Shell Oil North American and Global network and contracts with numerous large retailers including ExxonMobil, BP, and multiple retail chains. Under his leadership, Cybera’s annual revenue surged from a stable $27 million in annualized revenue to $49 million in just two years, achieving a compound annual growth rate (CAGR) of 48.5%. This rapid growth positioned Cybera as an attractive investment opportunity, enabling the CEO to successfully bring in Sumeru Capital and achieve the desired investor buyout. Gartner recognized Cybera’s innovation and market impact by naming it a “Cool Vendor,” solidifying its reputation as a leader in security solutions for distributed enterprises.

M2Gen, Inc. – Tripling Sales in Three Years and Securing $154 Million in Strategic Investment

Eric Anderson – M2Gen, Inc. CFO (Now Zephyr AI)

“Greg’s immediate willingness to spend hours to bring me up to speed as I entered my new role as CFO was a bit stunning in that it was clear his only objective was to help me and help me identify and tackle the precise challenges that M2Gen faced. Greg had already created an incredible business model that illuminated the path to revenue growth, and we jointly evolved the model to encompass new investor imperatives. Honestly, it was a unique pleasure to work with someone who had such a command of the market and could translate go-to-market plans into such detailed, concise, and organizationally validated budget plans.”

Greg Tennant joined M2Gen, Inc. during a critical turning point for the company. On his first day, the CEO informed him that M2Gen had lost major contracts with Merck and AbbVie, leading to company-wide furloughs and an urgent need for a turnaround strategy. Despite the challenging circumstances, Greg was tasked with repositioning M2Gen’s offerings, redefining its go-to-market strategy, and driving commercialization to save the organization. At the heart of M2Gen’s business was the Avatar database, a collection of consented and de-identified patient medical and genomic data designed for precision therapy development. However, the perpetual license model struggled to meet market demands, as clients sought the ability to purchase targeted data sets for specific cohorts. Recognizing this gap, Greg redefined the Avatar product, restructuring its data architecture and developing query tools to enable scalable, targeted data sales. Within the first year of the new strategy, M2Gen secured licensing agreements with four new clients, validating Greg’s approach, and positioning the company for growth. This success enabled M2Gen to raise $100 million in investments from Clayton, Dubilier & Rice (CD&R), Merck, and McKesson. Shortly thereafter, M2Gen drove the closure of a $54 million deal with Merck, further solidifying the company’s resurgence. Under Greg’s leadership, M2Gen expanded the Avatar database’s capabilities by integrating diagnostic imaging and metabolomics data, broadening its value to clients. He also diversified the company’s offerings to include clinical trial enablement, RWE insights, post-market observational programs, and academic-industry collaborations. By leveraging constant voice-of-customer feedback from both Pharma clients and ORIEN Network partners, M2Gen refined its product targeting and development to align with market needs. Greg’s innovative strategies and relentless execution not only tripled M2Gen’s sales over three years but also transformed the company into a trusted leader in the precision medicine and real-world data space.

Convergent Communications, Inc. – Scaling to $175M Annualized Revenues in Three Years

John Evans – Convergent Communications, Inc. CEO

“Greg is a highly motivated achiever with a great penchant for the details required to execute a product design and launch. He interacts well with the team and displays a broad understanding of the company’s strategic objectives while moving the day-to-day objectives ahead.”

Gregory Tennant joined Convergent Communications as Director of Marketing and quickly advanced to Senior Vice President of the Managed Services Division, where he spearheaded the development of a national VoIP and data network complemented by a suite of managed services and SaaS solutions. Gregory played a pivotal role in driving the Managed Services Division from inception to over $175 million in annualized revenues within just three years. Under his leadership, Gregory defined the product and go-to-market strategy, built a national sales and marketing organization, and established strategic partnerships with industry leaders such as Cisco and HP. His efforts included creating high-impact demand generation programs that propelled a compound annual growth rate (CAGR) of 432% over the period. Gregory also played a critical role in supporting the company’s public IPO process, collaborating with Goldman Sachs to position Convergent Communications as a leader in the rapidly expanding managed services and SaaS markets. His contributions established the foundation for Convergent’s growth and long-term success.